# Endothelial Dysfunction as a Risk Factor in HIV Study

> **NCT00039663** · PHASE1 · COMPLETED · sponsor: **National Institutes of Health Clinical Center (CC)** · enrollment: 75 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Pravastatin
- **DRUG:** Gemfibrozil
- **DRUG:** Rosiglitazone

## Key facts

- **NCT ID:** NCT00039663
- **Lead sponsor:** National Institutes of Health Clinical Center (CC)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** —
- **Final completion:** 2005-10
- **Target enrollment:** 75 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00039663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00039663, "Endothelial Dysfunction as a Risk Factor in HIV Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00039663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*